• News

Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstacles

  • The New York Times
  • New York, NY
  • (December 20, 2021)

Sam Gandy, MD, PhD, comments on Alzheimer's drug, aduhelm. Gandy said that with advocacy groups like the Alzheimer’s Association still supporting the drug’s approval, he had a “concern that calling for something may trigger a backlash that undoes where we really want to go.”

Learn more